NM_002117.6:c.620-56C>G
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_002117.6(HLA-C):c.620-56C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0 ( 0 hom., cov: 2)
Exomes 𝑓: 0.0000043 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
HLA-C
NM_002117.6 intron
NM_002117.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.25
Publications
27 publications found
Genes affected
HLA-C (HGNC:4933): (major histocompatibility complex, class I, C) HLA-C belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domain, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. About 6000 HLA-C alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002117.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HLA-C | NM_002117.6 | MANE Select | c.620-56C>G | intron | N/A | NP_002108.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HLA-C | ENST00000376228.10 | TSL:6 MANE Select | c.620-56C>G | intron | N/A | ENSP00000365402.5 | |||
| HLA-C | ENST00000383329.7 | TSL:6 | c.620-56C>G | intron | N/A | ENSP00000372819.3 | |||
| HLA-C | ENST00000415537.1 | TSL:6 | c.617-56C>G | intron | N/A | ENSP00000400410.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 56076Hom.: 0 Cov.: 2
GnomAD3 genomes
AF:
AC:
0
AN:
56076
Hom.:
Cov.:
2
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000428 AC: 3AN: 700142Hom.: 0 Cov.: 10 AF XY: 0.00000578 AC XY: 2AN XY: 345760 show subpopulations
GnomAD4 exome
AF:
AC:
3
AN:
700142
Hom.:
Cov.:
10
AF XY:
AC XY:
2
AN XY:
345760
show subpopulations
African (AFR)
AF:
AC:
0
AN:
11546
American (AMR)
AF:
AC:
0
AN:
17288
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
6020
East Asian (EAS)
AF:
AC:
1
AN:
11040
South Asian (SAS)
AF:
AC:
0
AN:
33294
European-Finnish (FIN)
AF:
AC:
0
AN:
25432
Middle Eastern (MID)
AF:
AC:
0
AN:
1870
European-Non Finnish (NFE)
AF:
AC:
1
AN:
565896
Other (OTH)
AF:
AC:
1
AN:
27756
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 56076Hom.: 0 Cov.: 2 AF XY: 0.00 AC XY: 0AN XY: 26620
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
56076
Hom.:
Cov.:
2
AF XY:
AC XY:
0
AN XY:
26620
African (AFR)
AF:
AC:
0
AN:
10906
American (AMR)
AF:
AC:
0
AN:
4944
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
750
East Asian (EAS)
AF:
AC:
0
AN:
1412
South Asian (SAS)
AF:
AC:
0
AN:
1516
European-Finnish (FIN)
AF:
AC:
0
AN:
4040
Middle Eastern (MID)
AF:
AC:
0
AN:
98
European-Non Finnish (NFE)
AF:
AC:
0
AN:
31314
Other (OTH)
AF:
AC:
0
AN:
658
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.